Product Reports Resources Pricing Login Book a demo

Ember LifeSciences

Home Living · Westlake Village, United States

A global temperature control brand and technology platform that pioneered the world's first temperature control mug MoreLess

Ember Life Sciences specializes in advanced temperature control solutions, focusing on reducing waste in pharmaceutical shipping. The company operates in the global logistics and healthcare markets, providing innovative products like the Ember Cube. This cloud-based SaaS dashboard integrates cellular radio and GPS to offer real-time location, temperature, and humidity tracking. The Ember Cube's return-to-sender feature significantly cuts down on shipping waste by replacing single-use materials such as Styrofoam, ice packs, and cardboard. Ember Life Sciences serves pharmaceutical companies and logistics providers, offering a subscription-based business model that generates revenue through recurring fees for its technology platform and services. The company's mission is to revolutionize the way temperature-sensitive products are shipped, ensuring precision, control, and accuracy. Keywords: temperature control, pharmaceutical shipping, SaaS, real-time tracking, waste reduction, GPS, cellular radio, logistics, healthcare, return-to-sender.

Company overview

Ember LifeSciences company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
Headquarters
Westlake Village, United States
Employees
26
Open positions
5
Dealroom signal
0.0
client focusb2cbusiness modelManufacturingsectorHard TechindustryHome Living

Valuation & funding

Ember LifeSciences funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCEquity / VC Jul 2026 $0 Alfresa
SERIES AEquity / VC Dec 2025 $27M $108M TDF Ventures · Amgen Ventures
EARLY VCEquity / VC Feb 2023 $0 Carrier Ventures
OtherOther financing Jun 2022 $0 Cardinal Health
OtherOther financing Dec 2021 $0 Cardinal Health
Showing 5 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 27
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Ember LifeSciences website traffic

Latest recorded traffic for Ember LifeSciences is 3.4K monthly website visits, up 88.9% over the last three months.

Latest monthly visits3.4K 3-month web change+88.9%
Monthly website visits45 observations · Oct 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Ember LifeSciences compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Ember LifeSciences's talent

Book a demo to see the people
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on Ember LifeSciences's cap table

Sourced from Dealroom's funding and investor records.

Series A 4 investors entered at this stage
Carrier Ventures
TDF Ventures
Amgen Ventures
Alfresa
Other known 2 additional known investors
Cardinal Health
Gozde Tech Ventures

Global footprint

Where Ember LifeSciences has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

In the news

Latest news about Ember LifeSciences

Recent press, funding announcements, and product moves mentioning Ember LifeSciences — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Ember LifeSciences

An AI-synthesized read of the highest-engagement posts about Ember LifeSciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ember LifeSciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.